Screener
SELLAS Life Sciences Group, Inc. SLS Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease liabilities | 562 | 544 |
| Total current liabilities | 6,456 | 7,017 |
| Operating lease liabilities, non-current | 309 | 457 |
| Total liabilities | 6,765 | 7,474 |
| Commitments and contingencies (Note 5) | ||
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value; 350,000,000 shares authorized, 181,332,574 and 153,103,459 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 18 | 15 |
| Additional paid-in capital | 390,789 | 345,844 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is SELLAS Life Sciences Group, Inc.'s total liabilities?
- SELLAS Life Sciences Group, Inc. (SLS) reported total liabilities of $6.77M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s total liabilities changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s total liabilities decreased by 6.0% year-over-year, from $7.2M to $6.77M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s total liabilities has grown at a -16.2% compound annual growth rate (CAGR), from $18.09M to $7.47M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about SELLAS Life Sciences Group, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude